Journal of Pain and Symptom Management
Volume 40, Issue 2 , Pages 266-278 , August 2010

A Randomized, Double-Blind, Double-Dummy Comparison of the Efficacy and Tolerability of Low-Dose Transdermal Buprenorphine (BuTrans® Seven-Day Patches) With Buprenorphine Sublingual Tablets (Temgesic®) in Patients With Osteoarthritis Pain

  • Ian G.V. James, MBChB, DCH, DRCOG

      Affiliations

    • Spring House Surgery, Bolton, Lancashire, United Kingdom
  • ,
  • Catherine M. O'Brien, MSc

      Affiliations

    • Fincham Statistics, King's Lynn, Norfolk, United Kingdom
  • ,
  • Chris J. McDonald, MBBS, MRCOphth, FFPM

      Affiliations

    • Medical Services and Pharmacovigilance, Napp Pharmaceuticals Limited, Cambridge, United Kingdom
    • Corresponding Author InformationAddress correspondence to: Chris J McDonald, MB, BS, Napp Pharmaceuticals Limited, Cambridge Science Park, Milton Road, Cambridge CB4 0GW, United Kingdom.

,Accepted 12 January 2010.

 This trial was sponsored by Napp Pharmaceuticals Limited, United Kingdom.

PII: S0885-3924(10)00324-6

doi: 10.1016/j.jpainsymman.2010.01.013

Journal of Pain and Symptom Management
Volume 40, Issue 2 , Pages 266-278 , August 2010